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doi:10.1016/j.kjms.2012.04.015Abstract We reviewed retrospectively the data for adult patients with bacterial meningitis
over a period of 10.5 years in our hospital. The clinical characteristics and laboratory data
of the 21 cases (52 strains) of mixed infection were analyzed. Two hundred and fifteen cases
of single pathogen adult bacterial meningitis (ABM) were also included for comparison. Post-
neurosurgical type of ABM was presented in 86% of the mixed infection group. Brain abscess
was found in three patients. Fourteen patients survived and seven cases died. The analysis
showed a statistical significance for the mixed infection group having a higher rate of
nosocomially-acquired, post-neurosurgical condition, hydrocephalus, and lower level of
cerebrospinal fluid white cell count, protein and lactate than the single pathogen group.
Logistic regression analysis showed the independent factor of “hydrocephalus” (p Z 0.002).
Presence of hydrocephalus is a significant neuroimaging feature when compared with the
single pathogen group. As compared with the previous study results of mixed infection in
ABM, the present study showed a change of pathogens implicated of increasing Pseudomonas
spp. and Acinetobacter spp. infections, and an emergence of anaerobic pathogens. All these
changes deserve special attention because of the need for an appropriate choice of empirical
antibiotics and choice of culture method.
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532 W.-C. Tsai et al.Introduction considered to have “mixed” bacterial meningitis if  2Adult bacterial meningitis (ABM) is a serious infectious
disease of the central nervous system (CNS) [1,2]; unlike
brain abscess, it is typically a mono-microbial infection [3].
Mixed infection in bacterial meningitis has been only rarely
examined in the literature [4,5]. Clinically, several factors
including varying periods of time may influence the change
of epidemiologic trend of ABM [1,2] and this change may
influence the choice of initial empirical antibiotics, which
has been known to be an important therapeutic strategy for
ABM management [6,7]. Therefore, a frequent review of
the epidemiologic trend of ABM is important for a better
therapeutic result. In the year 2000, we reported the
clinical and laboratory features of 12 cases of ABM with
mixed infection (study period: 1986e1998) [4], in which
a relatively high incidence of multi-antimicrobial resistant
strains was noted among the pathogens implicated. In the
present study, we analyzed the epidemiologic trend of
mixed infection in ABM patients, collected during a study
period of 10.5 years (January 2000eJune 2010), and made
a comparison with our previous report [4]. We also
compared the clinical and laboratory difference between
those ABM patients with mixed infection and with mono-
microbial infection. This comparison was not made in our
previous report [4] of mixed infection in ABM.
Patients and methods
We reviewed retrospectively the microbiological records for
cerebrospinal fluid (CSF) and medical records of adult
patients with bacterial meningitis admitted to our hospital
over a period of 10.5 years (January 2000eJune 2010). Our
hospital is a 2482-bed acute-care teaching hospital, which
serves as a primary and tertiary care center. In this study, the
criteria for a definite diagnosis of ABM were as follows [1,2]:
(A) age  17 years old; (B) positive CSF culture in patients
with clinical presentations of acute bacterial meningitis
including fever, headache, altered consciousness and
seizure; and (C) at least one of the following CSF parameters:
(1) a leukocyte count > 0.25  109/L with predominant
polymorphonuclear cells; (2) a CSF lactate concen-
tration> 3.5mmol/L; (3) a glucose ratio (CSF glucose/serum
glucose)< 0.4 or CSF glucose concentration< 2.5 mmol/L if
no simultaneous blood glucose was determined. Coagulase-
negative staphylococci were considered to be pathogenic
when positive cultures in  two separate CSF studies or one
positive CSF culture from the tip of indwelling neurosurgical
device [8]. The hospital’s Ethics Committee approved this
study (IRB 99-1897C).
In this study, “nosocomial” meningitis was defined as
infection not present when the patient was admitted to the
hospital and the clinical evidence of meningitis was
observed more than 48 hours after admission. Those with
clinical evidence of meningitis within 1 month after
discharge from the hospital where the patient had received
an invasive neurosurgical procedure were also included.
Meningitis related to traumatic skull fracture, neurosurgical
procedure or any causes related to skull defects was clas-
sified as the “post-neurosurgical” form. Otherwise, patients
were classified as the “spontaneous” form. Patients werebacterial organisms were isolated concomitantly from the
initial CSF cultures [4]. New pathogen(s) from new culture
during the therapeutic course of ABM was considered as
a state of “super-infection” [9]. Both the mixed infection
and super-infection were included in the group of “poly-
microbial infection”.
In this study, the analysis of antibiotic susceptibility was
based on the NCCLS/CLS standard methods. Intermediate
and resistant isolates were considered non-susceptible [10].
In this study period, vancomycin plus a third or fourth
generation cephalosporin were the initial empiric antibiotics
used in the treatment of patients with suspected ABM in our
hospital, and the antimicrobial regimen was adjusted
subsequently after the culture results were available.
For a comparative analysis, the clinical features of the
ABMpatientswithmixed infectionwere comparedwith those
ABM patients with single pathogen infection. The clinical
data including gender, type of infection, underlying condi-
tion, clinical presentations, antibiotics susceptibility, and
therapeutic outcomewere analyzed by the Fisher exact test.
The data for age, CSF white blood cell count, glucose level,
total protein, and lactate were compared using the Man-
neWhitney U test. Logistic regression analysis for indepen-
dent factors was also conducted. A p value < 0.05 was
considered statistically significant.Results
During the study period, 255 ABMpatientswere identified. Of
them, 215 patients had monomicrobial bacterial pathogen
infection (123 cases with Gram-negative [G(e)] pathogen
infection and 92 cases with Gram-positive [G(þ)] pathogen
infection while the other 40 cases had polymicrobial infec-
tion. Among the 40 cases of polymicrobial infection, 21 cases
had mixed infection from the initial CSF culture, and were
thus included in this study. The other 19 superinfection cases
were excluded in this study owing to the monomicrobial
infection from the first CSF culture. A total of 52 bacterial
strains were isolated from the 21 ABM patients with mixed
infection. Table 1 lists the pathogens implicated for the 236
ABM patients including 21 cases of mixed infection and 215
cases of monomicrobial infection. Among the implicated
G(e) pathogens found in ABM with monomicrobial infection,
Klebsiella pneumoniae was the most common, followed by
Acinetobacter spp. and Pseudomonas spp. As to the impli-
cated G(þ) pathogens, Staphylococcus aureus was the most
common, followed by coagulase-negative staphylococci,
Streptococcus pneumoniae and viridians streptococci. The
52 pathogens implicated found in the 21 ABM cases with
mixed infection included 40 strains of G(e) pathogens and 12
strains of G(þ) pathogens. Of the 40 strains of G(e) patho-
gens, seven strains belonged to anaerobic pathogens. Of the
implicated G(e) pathogens, Pseudomonas spp. (7) was the
most common, followed by Acinetobacter spp. (6), Escher-
ichia coli (6), Klebsiella spp. (4), Citrobacter spp. (2), Bre-
vundimonas diminuta (2), Elizabethkingia meningoseptica
(1), Alcaligenes faecalis (1), Comamonas acidovorans (1),
Shewanella putrefaciens (1), Enterobacter cloacae (1),
Proteus mirabilis (1), Fusobacterium nucleatum (1), Aero-
monas caviae (1), Bacteroides distaonis (1), Bacteroides
Table 1 The bacterial pathogens implicated in the present study (2000eJune 2010, both monomicrobial and mixed infections)
and in the previous study (1986e1998, mixed infection, [4]).
Pathogens Monomicrobial infection Mixed infection Previous study mixed infection
Gram negative 123 40 25
Klebsiella spp. 47 4 5
Klebsiella pneumoniae 47 3 4
Klebsiella oxytoca 1 1
Acinetobacter spp. 22 6 2
Acinetobacter baumannii 19 1 2
Acinetobacter lwoffii 2 1
Acinetobacter junnii 2
Acinetobacter sp. 1 2
Pseudomonas spp. 17 7 3
Pseudomonas aeruginosa 11 5 3
Psuedomonas spp. 6a 2
Enterobacter spp. 10 1 6
Enterobacter cloacae 7 1 5
Enterobacter aerogenes 3 1
Citrobacter 1 2 1
Citrobacter diversus 1 1 1
Citrobacter freundii 1
Escherichia coli 10 6 5
Serratia marcences 3 1
Proteus mirabilis 2 1 1
Brevundimonas diminuta 2
Elizabethkingia meningoseptica 1 1
Alcaligenes faecalis 1
Comamonas acidovorans 1
Shewanella putrefaciens 1
Neisseria meningitidis 2 1
Anaerobes 1b 7e
Others 7c
Gram positive 92 12 7
Staphylococcus spp. 53 5 4
Staphylococcus aureus 30 1 3
Staphylococcus epidermidis 10 2
Staphylococcus haemolyticus 2 1
Staphylococcus chromogenes 1
Unclassified coagulase-negative staphylococci 11 1
Streptococcus spp. 24 4 1
Streptococcus pneumoniae 12 1
Viridian streptococci 10 2 1
Beta-streptococci 2 1f
Enterococcus spp. 8 3 2
Others 7d
a Pseudomonas mendocina (2 strains), Pseudomonas stuzeri (2), Pseudomonas putida (1), and Pseudomonas sp. (1).
b Fusobacterium nucleatum.
c Salmonella (3), unclassified glucose non fermenting group (2), Sphingomonas paucimobilis (1), and Stenotrophomonasmaltophilia (1).
d Listeria monocyotgenes (3), Corynebacterium (3) and micrococcus (1).
e Fusobacterium nucleatum (1), Aeromonas caviae (1), Bacteroides distaonis (1), Bacteroides fragilis (1), Bacteroides uniformis (1),
Provetella sp. (1), and Provetella melaninogenica (1).
f group D streptococci.
Mixed infection in adult bacterial meningitis 533fragilis (1),Bacteroides uniformis (1), Provetella sp. (1), and
Provetella melaninogenica (1). The other 12 strains of G(þ)
pathogens included Staphylococcus aureus (1), Staphylo-
coccus epidermidis (2), Staphylococcus chromogenes (1),
unclassified coagulase-negative staphylococci (1), viridian
streptococci (2), Streptococcus pneumoniae (1), Group Bbeta-streptococci (1), andEnterococcus (3). For comparison,
Table 1 also lists the pathogens implicated from our previous
report of mixed infection in ABM [4].
The clinical features, underlying conditions, pathogens
implicated, and antibiotics used for treatment and ther-
apeutic outcome of the 21 ABM patients with a mixed
534 W.-C. Tsai et al.infection are shown in Tables 2 and 3. The 21 cases
included were 13 men and 8 women, aged 26e79 years
(median Z 59). Post-NS conditions as the preceding event
were noted in 18 patients (Cases 1e10, 14e21), and 14
(Cases 2e9, 16e21) of these 18 patients underwent an
insertion of ventriculoperitoneal (V-P) shunt or external
ventricular drainage (EVD). Among these 21 patients,
diabetes mellitus (DM) was the most common underlying
medical condition, found in four patients (Cases 1, 3, 8,
9). In this study period, the major antibiotics used for the
treatment included vancomycin, linezolid, ceftazidime,
cefepime, meropenem, and metronidazole in these 21
cases of mixed infection. With treatment, 14 of these 21
ABM patients with mixed infection survived and 7 of them
died.
The comparative results between the ABM patients with
mixed infection and those with monomicrobial infection are
listed in Table 3, and the significant factors included the
following: nosocomial infection, post-neurosurgical type,
hydrocephalus, CSF white blood cell (WBC) count, CSF
protein level, and CSF lactate level. Logistic regression
analysis showed that the presence of hydrocephalus
(p Z 0.002) was an independent factor.Discussion
In a large-scale study of ABM reported by Durand et al. [2],
mixed infection is found in 2% and 7% of the patients with
community-acquired and nosocomial infection, respec-
tively. In the present study, mixed infection was found in
8.2% (21/255) of the culture-proven ABM cases. Compared
with our previous study result [4], which showed an inci-
dence of 6.5%, the present figure is higher. Of the 21 ABM
patients with mixed infection, 86% (18/21) of them had
a preceding post-NS condition. This figure for incidence is
also higher than that (75%, 9/12) of our previous report of
mixed infection in ABM [4]. Therefore, this higher inci-
dence of mixed infection in ABM in the present study can
be attributed to the increased number of post-NS state in
our ABM patients, which has been noted in our recent
report of changing epidemiology of ABM [1]. In addition, as
shown in Table 3, the ABM patients with a mixed infection
also had a significantly higher incidence of hydrocephalus
and most of the patients contracted the infection noso-
comially. The high incidence of hydrocephalus among the
ABM patients with mixed infection can be related to the
high incidence of post-NS state as the preceding condition
of this group of patients. In the CSF study, when compared
with the ABM patients with monomicrobial infection, ABM
patients with mixed infection had a lower WBC count,
lower protein and lactate concentration. It is difficult to
explain the difference in CSF findings between these two
groups of ABM, the reason may be related to a high
percentage of patients in the post-neurosurgical state of
the mixed infection group. However, this significant
difference needs further large-scale study for a better
delineation. Therefore, a suspicion of ABM originating
from mixed infection should be kept in mind when facing
an ABM patient who has a post-NS state as the preceding
event; has hydrocephalus in neuroimaging study; and
contracts the infection nosocomially.Of the bacterial pathogens implicated from the present
21 ABM patients with mixed infection, G(e) pathogens were
the most common (77%, 40/52), followed by G(þ) patho-
gens (23%, 12/52). The anaerobic pathogens accounted for
13% of the 52 pathogens. In this specific infectious
syndrome, a relatively higher number of G(e) pathogen was
also noted in our previous report of mixed infection in ABM
[4]. In our previous study [4], Enterobacter spp., Escher-
ichia coli and Klebsiella spp. were the common G(e)
pathogens, while in the present study, Pseudomonas spp.
was the most common, followed by Acinetobacter spp. and
Escherichia coli. This change in relative frequency of
leading G(e) pathogens is consistent with the finding of
a recent report of changing epidemiology of overall ABM in
Taiwan [1]. Both Acinetobacter spp. and Pseudomonas spp.
are important causative pathogens of ABM patients with
a post-NS state as the preceding event and those who
contracted the infection nosocomially [1]. The high inci-
dence of multi-antibiotic resistant Acinetobacter spp. and
Pseudomonas spp. strains is also found in recent studies
[11e13] and deserves attention because it may influence
the choice of empiric antibiotics.
In this study, G(þ) pathogens accounted for 24.5% (12/
49) of the pathogens implicated of ABM with mixed infec-
tion, in which staphylococcal, streptococcal and entero-
coccal spp. were the common ones. This combination of
implicated G(þ) pathogens was the same as in our previous
report of mixed infection [4] and they are all common G(þ)
pathogens of ABM in Taiwan [1,4,10,14,15] and had high
incidence of antimicrobial resistance. Therefore, the
choice of vancomycin or linezolid as the antimicrobial
agent for their infection-related ABM was required and this
antibiotic choice was also noted in this study.
Compared with our previous study of mixed infection in
ABM [4], the most different finding in the present study was
the presence of anaerobic pathogens (Aeromonas caviae,
Bacteroides spp., Fusobacterium nucleatum and Prevotella
spp.) as the pathogens implicated. The lack of anaerobic
strains as the pathogens implicated in the previous studies
of mixed infection in bacterial meningitis [4,5] can be
partially because the anaerobic culture was not a routine
culture performed in clinical study. In present study, these
anaerobic pathogens accounted for 13.5% (7/52) of the
pathogens implicated for mixed infection in ABM. Pre-
votella meningitis was rarely reported and its infection was
noted mostly in children or adolescents [16e18]. In the
present two Prevotella infection-related ABM cases, one
had an underlying post-NS condition (Case 7) and one had
a co-existing brain abscess (Case 13). Aeromonas spp. is
a rare anaerobic pathogen for meningitis [19,20]; in this
study, Case 11 had a recent stomach operation and also had
respiratory failure as the preceding conditions of its
infection. CNS infections including meningitis and brain
abscess can be found in fusobacterial infection [21,22].
Case 13 had a coexisting brain abscess with this fuso-
bacterial (Fusobacterium nucleatum) infection. Bacteroid
spp. is not a common pathogen of ABM [23e25] and its
infection is usually seen in ABM patients with head and neck
tumor or with intracranial focal suppuration. In this study,
all two patients (Cases 2 and 16) had a preceding neuro-
surgical event as the underlying condition. Anaerobic
pathogens need a longer duration (10 dayse3 months) of
Table 2 The clinical data, pathogens implicated, antibiotics used and therapeutic outcome of the 21 adult bacterial meningitis patients with mixed infection.
Patient Age/Gender Underlying condition Pathogens Antibiotics Survived
1 57/F DM, Infarct, craniectomy, abscess Escherichia coli, Elizabethkingia meningoseptica ROC, CIP No
2 40/M SICH, craniectomy, EVD, VPS, cranioplasty Enterococcus, Klebsiella oxytoca,
Pseudomonas aeruginosa, Escherichia coli,
Bacteroides distaonis,a Bacteroides uniformisa
VA, CAZ, MET Yes
3 64/F DM, RHD, SICH, craniectomy, EVD Escherichia coli, Enterococcus VA, CAZ No
4 34/M TICH, craniectomy, VPS, cranioplasty Coagulase-negative staphylococci,
Staphylococcus chromogenes
LZD Yes
5 63/M SICH, craniotomy, EVD Citrobacter freundii, Escherichia coli MEP Yes
6 50/F Infarct, craniectomy, EVD Klebsiella pneumoniae, Enterobacter cloacae MAX Yes
7 26/M TICH, craniotomy, VPS Staphylococcus aureus, Prevotella sp.a LZD No
8 77/M DM, Hydrocephalus, VPS Staphylococcus epidermidis, Acinetobacter junnii VA, CAZ Yes
9 67/F DM, Infarct, hydrocephalus, EVD, VPS Alcaligenes faecalis, Comamonas acidovorans,
Brevundimonas diminuta
MEP Yes
10 44/M TICH, craniotomy, abscess Escherichia coli, Pseudomonas aeruginosa,
Streptococcus pneumoniae
VA, CAZ Yes
11 79/M Perforation peptic ulcer post operation Pseudomonas sp., Aeromonas caviae MEP Yes
12 78/F Pseudomonas sp., Acinetobacrer sp. MAX Yes
13 46/M Brain abscess Viridian streptococci, Fusobacterium nucleatum,a
Prevotella melaninogenicaa
VA, CAZ No
14 30/M TICH, craniectomy, cranioplasty Acinetobacter buamannii, viridian streptococci VA, MEP Yes
15 59/M SICH, craniotomy Acinetobacter spp, Brevundimonas diminuta MEP No
16 77/F SICH, craniotomy, VPS Bacteroides fragilis, Escherichia coli,
Klebisella pneumoniae, Group D streptococci
VA, ROC, MET Yes
17 58/F SICH, EVD Staphylococcus epidermidis, Acinetobacter lwoffii VA, ROC Yes
18 72/M SICH, VPS Pseudomonas aeruginosa, Citrobacter diversus MAX No
19 20/M TICH, EVD, VPS Pseudomonas aeruginosa,
Klebsiella pneumoniae, Proteus mirabilis
VA, MEP No
20 68/M SICH, EVD Acinetobacter junnii, Enterococcus faecalis VA, CAZ Yes
21 42/F SICH, EVD Pseudomonas aeruginosa, Shewanella putrefaciens MAX Yes
CAZZ ceftazidime; CIPZ ciprofloxacin; DM Z diabetes mellitus; EVD Z external ventricular drainage; F Z female; LZD Z linezolid; M Z male; MAX Z cefepime; MEP Z meropnem;
METZ metronidazole; RHDZ rheumatic heart disease; ROCZ ceftriaxone; SICHZ spontaneous intracranial hemorrhage; TICHZ traumatic intracranial hemorrhage; VAZ vancomycin;
VPS Z ventriculo-peritoneal shunt.
a Cultured from anaerobic culture.
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Table 3 Clinical and laboratory comparison between the adult bacterial meningitis patients with mixed infection and mon-
omicrobial infection.
Factors Mixed infection (n Z 21) Monomicrobial infection (n Z 215) p
Age (y); median (range) 59 (26e79) 56 (18e87) 0.748
Gender
Male 13 (62%) 152 (71%) 0.456
Female 8 (38%) 63 (29%)
Underlying condition
Diabetes mellitus 4 (19%) 58 (27%) 0.605
Liver cirrhosis 0 15 (7%) 0.373
Alcoholism 0 15 (7%) 0.373
Ear infection 0 6 (3%) 1.000
Drug abuser 0 6 (3%) 1.000
End stage renal diseases 0 9 (4%) 1.000
Malignancy 0 27 (12%) 0.143
Nosocomial-acquired 16 (76%) 113 (52%) 0.041*
Post-neurosurgical type 18 (86%) 130 (60%) 0.031*
Clinical presentation
Fever 18 (86%) 182 (85%) 1.000
Altered consciousness 9 (43%) 123 (57%) 0.252
Seizure 5 (24%) 56 (26%) 1.000
Shock 1 (5%) 25 (12%) 0.484
Hydrocephalus 14 (67%) 72 ((33%) 0.004*
Hyperglycemia hyperosmolarity syndrome 0 10 (5%) 0.606
Cerebrospinal fluid leak 1 (5%) 10 (5%) 1.000
Subdural empyema 0 9 (4%) 1.000
Brain abscess 3 (14%) 21 (10%) 0.458
Liver abscess 0 9 (4%) 1.000
Positive blood culture 2 (10%) 56 (26%) 0.114
Leukocytosis 15 (71%) 139 (65%) 0.636
Cerebrospinal fluid study, median (IQR) (25%, 75%)
White cell count (109/L) 0.06 (0.006, 0.175) 0.46 (0.10, 1.88) 0.001**
Glucose (mmol/L) 3.36 (2.14, 4.65) 2.48 (0.33, 4.13) 0.110
Protein (g/L) 0.73 (0.55, 1.80) 2.24 (0.95, 5.20) 0.005**
Lactate (mmol/L) 4.39 (2.39, 6.05) 9.02 (4.81, 16.50) 0.003**
Cases, non-susceptible to
Ceftazidime 7 (33%) 30 (14%) 0.250
Cefepime 3 (14%) 21 (10%) 1.000
Meropnem 3 (14%) 11 (5%) 0.390
Prognosis
Survived 14 (67%) 145 (67%) 1.000
Expired 7 (33%) 70 (33%)
* Fisher exact test (p < 0.05); ** Mann-Whitney U test (p < 0.05).
IQR Z interquartile range.
Logistic regression analysis showed independent factor of “hydrocephalus” (p Z 0.002).
536 W.-C. Tsai et al.antibiotic treatment [26,27]; therefore, the identification
of these uncommon pathogen-related infections in ABM is
extremely important because their infections need
a different consideration of antibiotic choice as well as
therapeutic course [26,27]. The antimicrobial agents such
as metronidazole, carbapenems, and a combination of
penicillin and beta-lactamase inhibitor are the antibiotics
of choice for treating anaerobic pathogen-related CNS
infections [17,27].In conclusion, mixed infection is not an uncommon
situation in ABM and its incidence is increasing. Usually this
group of patients has a post-NS state as the underlying
condition and contract the infection nosocomially. Pres-
ence of hydrocephalus is also a significant neuroimaging
feature when compared with the ABM with monomicrobial
infection. Compared with the previous report of mixed
infection of ABM, the present study showed the following
differences: (1) a change of the relative frequency of
Mixed infection in adult bacterial meningitis 537implicated G(e) pathogens; and (2) an emergence of
anaerobic bacteria as the pathogens implicated. All of
these changes deserve special attention because of the
need for an appropriate choice of empirical antibiotics and
choice of culture method.References
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